Antibiotic Use Guidelines

Introduction to Cephalosporins

• Cephalosporins are a class of antibiotics effective against various bacterial infections, with different generations offering distinct gram-positive and gram-negative coverage, as recommended by the Infectious Diseases Society of America 1, 2, 3, 4, 5
• The characteristics of different cephalosporin generations are summarized in the following table:

3, 4, 2, 5

First Generation Cephalosporins

• The American Heart Association recommends first-generation cephalosporins for treatment of staphylococcal and streptococcal infections in patients allergic to penicillins (except those with history of anaphylaxis, angioedema, or urticaria) 6
• First-generation cephalosporins, such as cephalexin, are ineffective clinically for Lyme disease due to inactivity against Borrelia burgdorferi 7
• First generation cephalosporins may be used for empiric therapy of mild diabetic foot infections without complicating factors, as recommended by the International Working Group on the Diabetic Foot and the American Diabetes Association 1, 3

Second Generation Cephalosporins

• Second generation cephalosporins are recommended for respiratory tract infections, sinusitis, and moderate-severe infections with mixed flora, by the American Academy of Allergy, Asthma, and Immunology 4
• Second generation cephalosporins should be considered when treating infections likely to involve both gram-positive and gram-negative organisms, particularly when anaerobic coverage is needed (cephamycins), as suggested by the Infectious Diseases Society of America 2

Third, Fourth, and Fifth Generation Cephalosporins

• Third generation cephalosporins are recommended for moderate to severe infections, meningitis, empiric therapy for community-acquired pneumonia, and complicated urinary tract infections, by the Infectious Diseases Society of America 2, 3
• Fourth generation cephalosporins are recommended for severe nosocomial infections and empiric therapy in immunocompromised patients, by the Infectious Diseases Society of America 5
• Fifth generation cephalosporins are recommended for complicated skin and soft tissue infections, including those with MRSA, community-acquired pneumonia, and hospital-acquired pneumonia (non-pseudomonal), by the Infectious Diseases Society of America 2

Administration and Dosage

• Cephalosporins are typically administered every 6-8 hours due to their shorter half-life, as recommended by the Infectious Diseases Society of America 2
• Dosage adjustments are required in patients with renal impairment, although the specific guidelines are not provided 2
• Cefazolin (IV) has a longer half-life (1.8 hours) compared to many other IV antibiotics, allowing for q8h dosing, as stated by the American Society of Health-System Pharmacists 1
• Cephalexin (PO) is rapidly absorbed and typically requires 4 times daily dosing, according to the National Institute of Allergy and Infectious Diseases 1
• Cefadroxil (PO) has an extended half-life, allowing for twice daily dosing and improving compliance, as noted by the Centers for Disease Control and Prevention 1
• Ceftriaxone is typically dosed at 1-2g IV daily, as per Clinical Microbiology and Infection and Clinical Infectious Diseases 8, 9, 10

Treatment Duration and Safety

• Cephalosporins should be used when their spectrum specifically matches the suspected pathogens rather than using broader spectrum agents, as recommended by the Infectious Diseases Society of America, although the strength of evidence is not specified 2
• The duration of antibiotic therapy should generally not exceed 7-14 days for most infections, with shorter durations (3-5 days) appropriate for many uncomplicated infections with adequate source control, as recommended by the World Society of Emergency Surgery 11
• Cephalosporins are generally well-tolerated, but may cause gastrointestinal disturbances, hypersensitivity reactions, and increase the risk of Clostridioides difficile infection, as stated by the American College of Gastroenterology 1, 5
• Combining antibiotics from the same class increases the risk of adverse effects without providing additional benefit, contributing to antimicrobial resistance, increased medication costs, and higher risk of drug interactions and adverse effects 8, 9